Clinical Trial Update: Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating switching to Tenofovir disoproxil fumarate versus continuing Lamivudine/Adefovir in lamivudine-resistant chronic hepatitis B patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Epivir (lamivudine) (lamivudine)
• Hepsera (Adefovir dipivoxil) (Adefovir dipivoxil)
• Viread (Tenofovir disoproxil fumarate) (Tenofovir disoproxil fumarate)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN